table of content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2032)
1.4.2 East Asia Market States and Outlook (2023-2032)
1.4.3 Europe Market States and Outlook (2023-2032)
1.4.4 South Asia Market States and Outlook (2023-2032)
1.4.5 Southeast Asia Market States and Outlook (2023-2032)
1.4.6 Middle East Market States and Outlook (2023-2032)
1.4.7 Africa Market States and Outlook (2023-2032)
1.4.8 Oceania Market States and Outlook (2023-2032)
1.4.9 South America Market States and Outlook (2023-2032)
1.5 Global Animal Model for Drug Testing Market Size Analysis from 2023 to 2032
1.5.1 Global Animal Model for Drug Testing Market Size Analysis from 2023 to 2032 by Consumption Volume
1.5.2 Global Animal Model for Drug Testing Market Size Analysis from 2023 to 2032 by Value
1.5.3 Global Animal Model for Drug Testing Price Trends Analysis from 2023 to 2032
1.6 COVID-19 Outbreak: Animal Model for Drug Testing Industry Impact
Chapter 2 Global Animal Model for Drug Testing Competition by Types, Applications, and Top Regions and Countries
2.1 Global Animal Model for Drug Testing (Volume and Value) by Type
2.1.1 Global Animal Model for Drug Testing Consumption and Market Share by Type (2017-2022)
2.1.2 Global Animal Model for Drug Testing Revenue and Market Share by Type (2017-2022)
2.2 Global Animal Model for Drug Testing (Volume and Value) by Application
2.2.1 Global Animal Model for Drug Testing Consumption and Market Share by Application (2017-2022)
2.2.2 Global Animal Model for Drug Testing Revenue and Market Share by Application (2017-2022)
2.3 Global Animal Model for Drug Testing (Volume and Value) by Regions
2.3.1 Global Animal Model for Drug Testing Consumption and Market Share by Regions (2017-2022)
2.3.2 Global Animal Model for Drug Testing Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Animal Model for Drug Testing Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global Animal Model for Drug Testing Consumption by Regions (2017-2022)
4.2 North America Animal Model for Drug Testing Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia Animal Model for Drug Testing Sales, Consumption, Export, Import (2017-2022)
4.4 Europe Animal Model for Drug Testing Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia Animal Model for Drug Testing Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia Animal Model for Drug Testing Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East Animal Model for Drug Testing Sales, Consumption, Export, Import (2017-2022)
4.8 Africa Animal Model for Drug Testing Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania Animal Model for Drug Testing Sales, Consumption, Export, Import (2017-2022)
4.10 South America Animal Model for Drug Testing Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America Animal Model for Drug Testing Market Analysis
5.1 North America Animal Model for Drug Testing Consumption and Value Analysis
5.1.1 North America Animal Model for Drug Testing Market Under COVID-19
5.2 North America Animal Model for Drug Testing Consumption Volume by Types
5.3 North America Animal Model for Drug Testing Consumption Structure by Application
5.4 North America Animal Model for Drug Testing Consumption by Top Countries
5.4.1 United States Animal Model for Drug Testing Consumption Volume from 2017 to 2022
5.4.2 Canada Animal Model for Drug Testing Consumption Volume from 2017 to 2022
5.4.3 Mexico Animal Model for Drug Testing Consumption Volume from 2017 to 2022
Chapter 6 East Asia Animal Model for Drug Testing Market Analysis
6.1 East Asia Animal Model for Drug Testing Consumption and Value Analysis
6.1.1 East Asia Animal Model for Drug Testing Market Under COVID-19
6.2 East Asia Animal Model for Drug Testing Consumption Volume by Types
6.3 East Asia Animal Model for Drug Testing Consumption Structure by Application
6.4 East Asia Animal Model for Drug Testing Consumption by Top Countries
6.4.1 China Animal Model for Drug Testing Consumption Volume from 2017 to 2022
6.4.2 Japan Animal Model for Drug Testing Consumption Volume from 2017 to 2022
6.4.3 South Korea Animal Model for Drug Testing Consumption Volume from 2017 to 2022
Chapter 7 Europe Animal Model for Drug Testing Market Analysis
7.1 Europe Animal Model for Drug Testing Consumption and Value Analysis
7.1.1 Europe Animal Model for Drug Testing Market Under COVID-19
7.2 Europe Animal Model for Drug Testing Consumption Volume by Types
7.3 Europe Animal Model for Drug Testing Consumption Structure by Application
7.4 Europe Animal Model for Drug Testing Consumption by Top Countries
7.4.1 Germany Animal Model for Drug Testing Consumption Volume from 2017 to 2022
7.4.2 UK Animal Model for Drug Testing Consumption Volume from 2017 to 2022
7.4.3 France Animal Model for Drug Testing Consumption Volume from 2017 to 2022
7.4.4 Italy Animal Model for Drug Testing Consumption Volume from 2017 to 2022
7.4.5 Russia Animal Model for Drug Testing Consumption Volume from 2017 to 2022
7.4.6 Spain Animal Model for Drug Testing Consumption Volume from 2017 to 2022
7.4.7 Netherlands Animal Model for Drug Testing Consumption Volume from 2017 to 2022
7.4.8 Switzerland Animal Model for Drug Testing Consumption Volume from 2017 to 2022
7.4.9 Poland Animal Model for Drug Testing Consumption Volume from 2017 to 2022
Chapter 8 South Asia Animal Model for Drug Testing Market Analysis
8.1 South Asia Animal Model for Drug Testing Consumption and Value Analysis
8.1.1 South Asia Animal Model for Drug Testing Market Under COVID-19
8.2 South Asia Animal Model for Drug Testing Consumption Volume by Types
8.3 South Asia Animal Model for Drug Testing Consumption Structure by Application
8.4 South Asia Animal Model for Drug Testing Consumption by Top Countries
8.4.1 India Animal Model for Drug Testing Consumption Volume from 2017 to 2022
8.4.2 Pakistan Animal Model for Drug Testing Consumption Volume from 2017 to 2022
8.4.3 Bangladesh Animal Model for Drug Testing Consumption Volume from 2017 to 2022
Chapter 9 Southeast Asia Animal Model for Drug Testing Market Analysis
9.1 Southeast Asia Animal Model for Drug Testing Consumption and Value Analysis
9.1.1 Southeast Asia Animal Model for Drug Testing Market Under COVID-19
9.2 Southeast Asia Animal Model for Drug Testing Consumption Volume by Types
9.3 Southeast Asia Animal Model for Drug Testing Consumption Structure by Application
9.4 Southeast Asia Animal Model for Drug Testing Consumption by Top Countries
9.4.1 Indonesia Animal Model for Drug Testing Consumption Volume from 2017 to 2022
9.4.2 Thailand Animal Model for Drug Testing Consumption Volume from 2017 to 2022
9.4.3 Singapore Animal Model for Drug Testing Consumption Volume from 2017 to 2022
9.4.4 Malaysia Animal Model for Drug Testing Consumption Volume from 2017 to 2022
9.4.5 Philippines Animal Model for Drug Testing Consumption Volume from 2017 to 2022
9.4.6 Vietnam Animal Model for Drug Testing Consumption Volume from 2017 to 2022
9.4.7 Myanmar Animal Model for Drug Testing Consumption Volume from 2017 to 2022
Chapter 10 Middle East Animal Model for Drug Testing Market Analysis
10.1 Middle East Animal Model for Drug Testing Consumption and Value Analysis
10.1.1 Middle East Animal Model for Drug Testing Market Under COVID-19
10.2 Middle East Animal Model for Drug Testing Consumption Volume by Types
10.3 Middle East Animal Model for Drug Testing Consumption Structure by Application
10.4 Middle East Animal Model for Drug Testing Consumption by Top Countries
10.4.1 Turkey Animal Model for Drug Testing Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia Animal Model for Drug Testing Consumption Volume from 2017 to 2022
10.4.3 Iran Animal Model for Drug Testing Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates Animal Model for Drug Testing Consumption Volume from 2017 to 2022
10.4.5 Israel Animal Model for Drug Testing Consumption Volume from 2017 to 2022
10.4.6 Iraq Animal Model for Drug Testing Consumption Volume from 2017 to 2022
10.4.7 Qatar Animal Model for Drug Testing Consumption Volume from 2017 to 2022
10.4.8 Kuwait Animal Model for Drug Testing Consumption Volume from 2017 to 2022
10.4.9 Oman Animal Model for Drug Testing Consumption Volume from 2017 to 2022
Chapter 11 Africa Animal Model for Drug Testing Market Analysis
11.1 Africa Animal Model for Drug Testing Consumption and Value Analysis
11.1.1 Africa Animal Model for Drug Testing Market Under COVID-19
11.2 Africa Animal Model for Drug Testing Consumption Volume by Types
11.3 Africa Animal Model for Drug Testing Consumption Structure by Application
11.4 Africa Animal Model for Drug Testing Consumption by Top Countries
11.4.1 Nigeria Animal Model for Drug Testing Consumption Volume from 2017 to 2022
11.4.2 South Africa Animal Model for Drug Testing Consumption Volume from 2017 to 2022
11.4.3 Egypt Animal Model for Drug Testing Consumption Volume from 2017 to 2022
11.4.4 Algeria Animal Model for Drug Testing Consumption Volume from 2017 to 2022
11.4.5 Morocco Animal Model for Drug Testing Consumption Volume from 2017 to 2022
Chapter 12 Oceania Animal Model for Drug Testing Market Analysis
12.1 Oceania Animal Model for Drug Testing Consumption and Value Analysis
12.2 Oceania Animal Model for Drug Testing Consumption Volume by Types
12.3 Oceania Animal Model for Drug Testing Consumption Structure by Application
12.4 Oceania Animal Model for Drug Testing Consumption by Top Countries
12.4.1 Australia Animal Model for Drug Testing Consumption Volume from 2017 to 2022
12.4.2 New Zealand Animal Model for Drug Testing Consumption Volume from 2017 to 2022
Chapter 13 South America Animal Model for Drug Testing Market Analysis
13.1 South America Animal Model for Drug Testing Consumption and Value Analysis
13.1.1 South America Animal Model for Drug Testing Market Under COVID-19
13.2 South America Animal Model for Drug Testing Consumption Volume by Types
13.3 South America Animal Model for Drug Testing Consumption Structure by Application
13.4 South America Animal Model for Drug Testing Consumption Volume by Major Countries
13.4.1 Brazil Animal Model for Drug Testing Consumption Volume from 2017 to 2022
13.4.2 Argentina Animal Model for Drug Testing Consumption Volume from 2017 to 2022
13.4.3 Columbia Animal Model for Drug Testing Consumption Volume from 2017 to 2022
13.4.4 Chile Animal Model for Drug Testing Consumption Volume from 2017 to 2022
13.4.5 Venezuela Animal Model for Drug Testing Consumption Volume from 2017 to 2022
13.4.6 Peru Animal Model for Drug Testing Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico Animal Model for Drug Testing Consumption Volume from 2017 to 2022
13.4.8 Ecuador Animal Model for Drug Testing Consumption Volume from 2017 to 2022
Chapter 14 Company Profiles and Key Figures in Animal Model for Drug Testing Business
14.1 Charles River Laboratories
14.1.1 Charles River Laboratories Company Profile
14.1.2 Charles River Laboratories Animal Model for Drug Testing Product Specification
14.1.3 Charles River Laboratories Animal Model for Drug Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 Envigo
14.2.1 Envigo Company Profile
14.2.2 Envigo Animal Model for Drug Testing Product Specification
14.2.3 Envigo Animal Model for Drug Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 Taconic Biosciences
14.3.1 Taconic Biosciences Company Profile
14.3.2 Taconic Biosciences Animal Model for Drug Testing Product Specification
14.3.3 Taconic Biosciences Animal Model for Drug Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Jackson Laboratory
14.4.1 Jackson Laboratory Company Profile
14.4.2 Jackson Laboratory Animal Model for Drug Testing Product Specification
14.4.3 Jackson Laboratory Animal Model for Drug Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 Crown Biosciences
14.5.1 Crown Biosciences Company Profile
14.5.2 Crown Biosciences Animal Model for Drug Testing Product Specification
14.5.3 Crown Biosciences Animal Model for Drug Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 Shanghai SLAC
14.6.1 Shanghai SLAC Company Profile
14.6.2 Shanghai SLAC Animal Model for Drug Testing Product Specification
14.6.3 Shanghai SLAC Animal Model for Drug Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 Shangghai Modelorg
14.7.1 Shangghai Modelorg Company Profile
14.7.2 Shangghai Modelorg Animal Model for Drug Testing Product Specification
14.7.3 Shangghai Modelorg Animal Model for Drug Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.8 GenOway
14.8.1 GenOway Company Profile
14.8.2 GenOway Animal Model for Drug Testing Product Specification
14.8.3 GenOway Animal Model for Drug Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.9 Syngene International
14.9.1 Syngene International Company Profile
14.9.2 Syngene International Animal Model for Drug Testing Product Specification
14.9.3 Syngene International Animal Model for Drug Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.10 Psychogenics
14.10.1 Psychogenics Company Profile
14.10.2 Psychogenics Animal Model for Drug Testing Product Specification
14.10.3 Psychogenics Animal Model for Drug Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.11 Pharmaron
14.11.1 Pharmaron Company Profile
14.11.2 Pharmaron Animal Model for Drug Testing Product Specification
14.11.3 Pharmaron Animal Model for Drug Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.12 Pharmalegacy
14.12.1 Pharmalegacy Company Profile
14.12.2 Pharmalegacy Animal Model for Drug Testing Product Specification
14.12.3 Pharmalegacy Animal Model for Drug Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.13 Vitalstar Biotechnology
14.13.1 Vitalstar Biotechnology Company Profile
14.13.2 Vitalstar Biotechnology Animal Model for Drug Testing Product Specification
14.13.3 Vitalstar Biotechnology Animal Model for Drug Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global Animal Model for Drug Testing Market Forecast (2023-2032)
15.1 Global Animal Model for Drug Testing Consumption Volume, Revenue and Price Forecast (2023-2032)
15.1.1 Global Animal Model for Drug Testing Consumption Volume and Growth Rate Forecast (2023-2032)
15.1.2 Global Animal Model for Drug Testing Value and Growth Rate Forecast (2023-2032)
15.2 Global Animal Model for Drug Testing Consumption Volume, Value and Growth Rate Forecast by Region (2023-2032)
15.2.1 Global Animal Model for Drug Testing Consumption Volume and Growth Rate Forecast by Regions (2023-2032)
15.2.2 Global Animal Model for Drug Testing Value and Growth Rate Forecast by Regions (2023-2032)
15.2.3 North America Animal Model for Drug Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2032)
15.2.4 East Asia Animal Model for Drug Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2032)
15.2.5 Europe Animal Model for Drug Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2032)
15.2.6 South Asia Animal Model for Drug Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2032)
15.2.7 Southeast Asia Animal Model for Drug Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2032)
15.2.8 Middle East Animal Model for Drug Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2032)
15.2.9 Africa Animal Model for Drug Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2032)
15.2.10 Oceania Animal Model for Drug Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2032)
15.2.11 South America Animal Model for Drug Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2032)
15.3 Global Animal Model for Drug Testing Consumption Volume, Revenue and Price Forecast by Type (2023-2032)
15.3.1 Global Animal Model for Drug Testing Consumption Forecast by Type (2023-2032)
15.3.2 Global Animal Model for Drug Testing Revenue Forecast by Type (2023-2032)
15.3.3 Global Animal Model for Drug Testing Price Forecast by Type (2023-2032)
15.4 Global Animal Model for Drug Testing Consumption Volume Forecast by Application (2023-2032)
15.5 Animal Model for Drug Testing Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
